S 
90.43
+0.06%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$8.32bn
FY2020FY2025
Net income
$1.56bn
FY2020FY2025
Free cash flow
−$10.0m
FY2020FY2025
Shareholders' equity
$5.05bn
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | $8.32bn | $8.25bn | $8.20bn | $8.13bn | $8.17bn | $7.28bn |
| Gross profit | $4.45bn | $4.59bn | $4.69bn | $4.70bn | $4.92bn | $4.32bn |
| Research and development | $739.0m | $775.0m | $758.0m | $767.0m | $766.0m | $719.0m |
| Operating income | $2.18bn | $972.0m | $1.69bn | $1.69bn | $1.88bn | $1.43bn |
| Net income | $1.56bn | $479.0m | $1.35bn | $1.34bn | $1.46bn | $1.14bn |
| Diluted earnings per share | 8.88 | 2.74 | 7.79 | 7.79 | 8.47 | 6.60 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | $14.29bn | $14.46bn | $13.94bn | $13.59bn | $14.07bn | — |
| Cash and short-term investments | $878.0m | $762.0m | $194.0m | $61.0m | $91.0m | — |
| Total liabilities | $9.24bn | $11.50bn | $2.28bn | $1.85bn | $2.02bn | — |
| Debt | $5.04bn | $8.01bn | — | — | — | — |
| Shareholders' equity | $5.05bn | $2.96bn | $11.67bn | $11.74bn | $12.06bn | — |
| Shares outstanding | 175m | 175m | 173m | 172m | 172m | 172m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | $369.0m | $1.19bn | $1.92bn | $1.68bn | $2.20bn | $2.03bn |
| Capital spending | −$379.0m | −$380.0m | −$290.0m | −$251.0m | −$277.0m | −$271.0m |
| Free cash flow | −$10.0m | $805.0m | $1.63bn | $1.43bn | $1.93bn | $1.75bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21bn | $2.01bn | $2.00bn | $2.10bn | $2.16bn | $2.07bn | $2.08bn | $2.08bn |
| Gross profit | $1.29bn | $1.10bn | $985.0m | $1.18bn | $1.18bn | $1.11bn | $1.12bn | $1.17bn |
| Operating income | $181.0m | $81.0m | $109.0m | $226.0m | $214.0m | $142.0m | $136.0m | $275.0m |
| Net income | $92.0m | $13.0m | $63.0m | $1.27bn | $90.0m | $137.0m | $31.0m | $122.0m |
| Diluted earnings per share | 0.53 | 0.07 | 0.36 | 7.22 | 0.51 | 0.78 | 0.18 | 0.70 |
| Cash from operations | $227.0m | −$189.0m | $95.0m | $76.0m | $169.0m | $29.0m | $219.0m | $169.0m |
| Capital spending | −$83.0m | −$84.0m | −$63.0m | −$97.0m | −$110.0m | −$109.0m | −$127.0m | −$93.0m |
| Free cash flow | $144.0m | −$273.0m | $32.0m | −$21.0m | $59.0m | −$80.0m | $92.0m | $76.0m |
| Total assets | $14.24bn | $14.10bn | $14.29bn | $13.97bn | $15.07bn | $14.53bn | $14.46bn | $14.74bn |
| Cash and short-term investments | $403.0m | $561.0m | $878.0m | $1.64bn | $492.0m | $534.0m | $762.0m | $772.0m |
| Debt | $5.08bn | $5.08bn | $5.04bn | $5.14bn | $7.82bn | $7.91bn | $8.01bn | $8.11bn |
| Shareholders' equity | $4.80bn | $4.97bn | $5.05bn | $4.99bn | $3.65bn | $3.26bn | $2.96bn | $3.19bn |
Financial ratios
Data as of 2 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 53.5% | 55.6% | 57.3% | 57.7% | 60.2% | 59.3% |
| Operating margin | 26.2% | 11.8% | 20.6% | 20.8% | 23.0% | 19.6% |
| Net margin | 18.7% | 5.8% | 16.4% | 16.5% | 17.9% | 15.6% |
| Return on equity | 30.8% | 16.2% | 11.5% | 11.4% | 12.1% | — |
| Return on assets | 10.9% | 3.3% | 9.7% | 9.9% | 10.4% | — |
| Free cash flow yield | 4.9% | 10.2% | 14.5% | 12.7% | — | — |
| Revenue growth | 0.9% | 0.7% | 0.8% | -0.5% | 12.2% | — |
| Earnings growth | 224.8% | -64.4% | 0.2% | -8.0% | 28.3% | — |
| Current ratio | 1.23x | 1.20x | 1.46x | 1.70x | 1.56x | — |
| Debt to equity | 1.00x | 2.71x | 0.71x | 0.00x | 0.00x | — |
| Equity ratio | 35.3% | 20.5% | 83.7% | 86.4% | 85.7% | — |
| Interest coverage | 6.29x | 2.65x | — | — | — | — |
| R&D as a share of sales | 8.9% | 9.4% | 9.2% | 9.4% | 9.4% | 9.9% |
| Buybacks as a share of market value | -0.5% | -1.0% | -0.1% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.8% | 2.7% | — |
| Operating income | 8.8% | 8.8% | — |
| Net income | 5.0% | 6.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 54.6% | 56.0% | 57.2% | — |
| Operating margin | 19.0% | 19.9% | 20.4% | — |
| Net margin | 12.3% | 14.4% | 15.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | 8.9 | 24.1 |
| Price to sales | 1.7 | 1.4 |
Market value over time
28 Mar 2024 to 1 Oct 2026, in USD
$12.03bn$15.31bn
Share price return
Finished calendar years
| 2025 | 2024 | |
|---|---|---|
| Return | 21% | -16% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.